S&W SEED CO (SANW)

US7851351046 - Common Stock

0.38  +0.01 (+1.41%)

After market: 0.37 -0.01 (-2.63%)

Fundamental Rating

2

Overall SANW gets a fundamental rating of 2 out of 10. We evaluated SANW against 93 industry peers in the Food Products industry. Both the profitability and financial health of SANW have multiple concerns. SANW is valied quite expensively at the moment, while it does show a decent growth rate.



3

1. Profitability

1.1 Basic Checks

SANW had negative earnings in the past year.
In the past year SANW has reported a negative cash flow from operations.
SANW had negative earnings in 4 of the past 5 years.
SANW had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

SANW has a Return On Assets of 8.36%. This is amongst the best in the industry. SANW outperforms 85.87% of its industry peers.
Looking at the Return On Equity, with a value of 19.28%, SANW belongs to the top of the industry, outperforming 89.13% of the companies in the same industry.
Industry RankSector Rank
ROA 8.36%
ROE 19.28%
ROIC N/A
ROA(3y)-10.29%
ROA(5y)-9.97%
ROE(3y)-24.05%
ROE(5y)-21.12%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With an excellent Profit Margin value of 17.65%, SANW belongs to the best of the industry, outperforming 93.48% of the companies in the same industry.
SANW has a Gross Margin (22.91%) which is in line with its industry peers.
SANW's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 17.65%
GM 22.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.77%
GM growth 5Y-3.1%

1

2. Health

2.1 Basic Checks

SANW does not have a ROIC to compare to the WACC, probably because it is not profitable.
SANW has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SANW has been increased compared to 5 years ago.
Compared to 1 year ago, SANW has a worse debt to assets ratio.

2.2 Solvency

SANW has an Altman-Z score of -0.77. This is a bad value and indicates that SANW is not financially healthy and even has some risk of bankruptcy.
SANW's Altman-Z score of -0.77 is on the low side compared to the rest of the industry. SANW is outperformed by 76.09% of its industry peers.
A Debt/Equity ratio of 0.78 indicates that SANW is somewhat dependend on debt financing.
SANW's Debt to Equity ratio of 0.78 is in line compared to the rest of the industry. SANW outperforms 40.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Altman-Z -0.77
ROIC/WACCN/A
WACC8.11%

2.3 Liquidity

SANW has a Current Ratio of 1.04. This is a normal value and indicates that SANW is financially healthy and should not expect problems in meeting its short term obligations.
SANW's Current ratio of 1.04 is on the low side compared to the rest of the industry. SANW is outperformed by 73.91% of its industry peers.
SANW has a Quick Ratio of 1.04. This is a bad value and indicates that SANW is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.42, SANW is not doing good in the industry: 85.87% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 0.42

5

3. Growth

3.1 Past

SANW shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.54%, which is quite good.
The Revenue has been growing slightly by 2.94% in the past year.
The Revenue has been growing slightly by 2.77% on average over the past years.
EPS 1Y (TTM)17.54%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-42.86%
Revenue 1Y (TTM)2.94%
Revenue growth 3Y-2.62%
Revenue growth 5Y2.77%
Revenue growth Q2Q3.78%

3.2 Future

SANW is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.34% yearly.
SANW is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.44% yearly.
EPS Next Y-6.74%
EPS Next 2Y23.51%
EPS Next 3Y21.34%
EPS Next 5YN/A
Revenue Next Year9.92%
Revenue Next 2Y12.7%
Revenue Next 3Y13.44%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

SANW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SANW. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

SANW's earnings are expected to grow with 21.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.51%
EPS Next 3Y21.34%

0

5. Dividend

5.1 Amount

No dividends for SANW!.
Industry RankSector Rank
Dividend Yield N/A

S&W SEED CO

NASDAQ:SANW (5/17/2024, 4:22:18 PM)

After market: 0.37 -0.01 (-2.63%)

0.38

+0.01 (+1.41%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap16.46M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.36%
ROE 19.28%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 17.65%
GM 22.91%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.04
Quick Ratio 0.42
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)17.54%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-6.74%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)2.94%
Revenue growth 3Y-2.62%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y